Solid Biosciences Inc. SLDB Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Research And Development Expense by Product | ||||||
| Internal Research And Development Expense | $31.64M+36.6% | $29.34M+35.2% | $27.23M+29.2% | $25.02M+18.0% | $23.17M+6.7% | |
| SGT003 | $72.12M+221% | $58.34M+284% | $44.95M+204% | $32.24M+118% | $22.46M+28.0% | |
| SGT501 | $6.58M-63.2% | $9.64M-44.0% | $14.89M+31.4% | $16.68M+89.0% | $17.88M+188% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Solid Biosciences Inc. break its business down?
- Solid Biosciences Inc. (SLDB) reports research and development expense by product across 4 parts — External General And Administrative Expense, Internal Research And Development Expense, SGT003 and SGT501. Each is extracted from the segment footnotes and tracked over time.
- Where does Solid Biosciences Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Solid Biosciences Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
